Zhe Liu

5.0k total citations
90 papers, 849 citations indexed

About

Zhe Liu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Zhe Liu has authored 90 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 31 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Zhe Liu's work include Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Research Studies (12 papers) and Cancer Genomics and Diagnostics (8 papers). Zhe Liu is often cited by papers focused on Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Research Studies (12 papers) and Cancer Genomics and Diagnostics (8 papers). Zhe Liu collaborates with scholars based in China, United States and Netherlands. Zhe Liu's co-authors include Liang Shi, Tong Li, Hong Tao, Xiaomei Shao, Robert Tjian, Jianqiao Fang, Wenxin Hu, Junfan Fang, Tong Li and Li Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Zhe Liu

84 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhe Liu China 18 314 293 236 98 94 90 849
Jung Hoon Kim South Korea 16 180 0.6× 338 1.2× 150 0.6× 123 1.3× 100 1.1× 35 737
Nikolaj Frost Germany 16 400 1.3× 368 1.3× 194 0.8× 95 1.0× 102 1.1× 58 1.0k
Milena Braga‐Basaria United States 12 467 1.5× 212 0.7× 254 1.1× 136 1.4× 72 0.8× 21 1.2k
Huichuan Yu China 16 125 0.4× 392 1.3× 272 1.2× 128 1.3× 206 2.2× 61 880
M. Lloret Spain 20 205 0.7× 311 1.1× 231 1.0× 179 1.8× 183 1.9× 50 890
Konstantinos Papadimitriou Greece 12 92 0.3× 340 1.2× 150 0.6× 120 1.2× 78 0.8× 51 724
Visalini Nair‐Shalliker Australia 15 107 0.3× 128 0.4× 185 0.8× 41 0.4× 108 1.1× 29 659
Yan Xue China 16 113 0.4× 97 0.3× 249 1.1× 160 1.6× 152 1.6× 59 799
Yajun Li China 17 84 0.3× 242 0.8× 172 0.7× 100 1.0× 146 1.6× 79 761

Countries citing papers authored by Zhe Liu

Since Specialization
Citations

This map shows the geographic impact of Zhe Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe Liu more than expected).

Fields of papers citing papers by Zhe Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhe Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe Liu. The network helps show where Zhe Liu may publish in the future.

Co-authorship network of co-authors of Zhe Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhe Liu. A scholar is included among the top collaborators of Zhe Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhe Liu. Zhe Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Huiping, Jiahui Jiang, Zhe Liu, et al.. (2024). Multiparametric MRI-Based Machine Learning Models for the Characterization of Cystic Renal Masses Compared to the Bosniak Classification, Version 2019: A Multicenter Study. Academic Radiology. 31(8). 3223–3234. 1 indexed citations
2.
Hu, Zhichao, Hongjun Zhuang, Li-Yi Zhang, et al.. (2024). A nanoenzyme reactor fueled by a High-Glucose microenvironment for augmented diabetic tumor therapy. Chemical Engineering Journal. 497. 154505–154505. 2 indexed citations
3.
Zhao, Jun, Jian Fang, Yan Yu, et al.. (2024). Updated safety and efficacy data of combined KRAS G12C inhibitor (glecirasib, JAB-21822) and SHP2 inhibitor (JAB-3312) in patients with KRAS p.G12C mutated solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 3008–3008. 12 indexed citations
4.
Shi, Liang, Shuhong Gao, Tong Li, et al.. (2023). Pathological complete response to long-course neoadjuvant alectinib in lung adenocarcinoma with EML4-ALK rearrangement: report of two cases and systematic review of case reports. Frontiers in Oncology. 13. 1120511–1120511. 4 indexed citations
5.
Song, Rui, Xiaoyou Chen, Liang Xiao, et al.. (2023). Nasal spray of an IgM‐like ACE2 fusion protein HH‐120 prevents SARS‐CoV‐2 infection: Two investigator‐initiated postexposure prophylaxis trials. Journal of Medical Virology. 95(12). 1 indexed citations
7.
Zhou, Qing, Shun Lü, Yong Li, et al.. (2022). [Chinese Expert Consensus on Management of Special Adverse Effects 
Associated with Lorlatinib].. SHILAP Revista de lepidopterología. 25(8). 555–566. 3 indexed citations
8.
Zhu, Yingting, et al.. (2021). Demyelination of the Optic Nerve: An Underlying Factor in Glaucoma?. Frontiers in Aging Neuroscience. 13. 701322–701322. 10 indexed citations
9.
Liu, Zhe, et al.. (2021). Bone marrow-derived mesenchymal stem cells inhibit CD8+ T cell immune responses via PD-1/PD-L1 pathway in multiple myeloma. Clinical & Experimental Immunology. 205(1). 53–62. 18 indexed citations
10.
Shi, Liang, Hong Tao, Lili Guo, et al.. (2021). Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases. Frontiers in Oncology. 11. 622142–622142. 8 indexed citations
11.
Ma, Gang, Guichen Li, Yuanhong Xu, et al.. (2021). Primary gastric melanoma with pancreatic metastasis: a case report. Annals of Palliative Medicine. 10(5). 5902–5907. 2 indexed citations
13.
Liu, Zhe, Xiaogang Bai, & Jing Wang. (2017). A rare case of report of primary cardiac liposarcoma infiltrating the left atrium and mitral valve. Biomedical Research-tokyo. 28(17). 7451–7453. 1 indexed citations
14.
Shi, Liang, Zhe Liu, Hongbo Wu, et al.. (2017). JCES01.23 EGFR Mutation Status Analysis in Cerebrospinal Fluid and Plasma of Advanced Lung Adenocarcinoma with Brain Metastases. Journal of Thoracic Oncology. 12(1). S240–S240. 1 indexed citations
15.
Tao, Hong, Yiran Cai, Liang Shi, et al.. (2016). Analysis of clinical characteristics and prognosis of patients with anaplastic lymphoma kinase‐positive and surgically resected lung adenocarcinoma. Thoracic Cancer. 8(1). 8–15. 13 indexed citations
17.
Feng, Jun, et al.. (2011). Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta-analysis of the literature. Archives of Gynecology and Obstetrics. 285(5). 1407–1413. 32 indexed citations
18.
Wu, Weihua, Jing Mu, Tong Li, & Zhe Liu. (2011). Primary lung squamous cell carcinoma ileocecal metastasis: one case report and literature review. Chinese Journal of Asthma. 31(16). 1225–1227. 2 indexed citations
19.
Zhang, Xinyong, Li‐Yan Xu, Hui Wang, et al.. (2008). [The relationship between EGFR mutations and response and prognosis of tyrosine kinase inhibitors in advanced Non-small-cell Lung Cancer.].. SHILAP Revista de lepidopterología. 11(2). 206–13. 3 indexed citations
20.
Liu, Zhe. (2005). Clinical Research of Shengmai Injection in Preventing and Treating radi ation-induced pulmonary injury. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026